urs-12-烯-3-醇,(3b,19a,20b)-(9CI) | 638-95-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: urs-12-烯-3-醇,(3b,19a,20b)-(9CI)
• 英文名称: α-amyrin
• 英文别名: (3S,6aR,6bS,8aR,11R,12S,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol
• CAS: 638-95-9；5937-48-4；101915-51-9
• 化学式: C₃₀H₅₀O
• 分子量: 426.726
• InChiKey: FSLPMRQHCOLESF-LIYBYQANSA-N

物化性质

• 熔点：
  134-137 °C
• 沸点：
  493.8±45.0 °C(Predicted)
• 密度：
  1.01±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  9
• 重原子数：
  31
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 危险品运输编号：
  HAZARD
• WGK Germany：
  3

文献信息

• [EN] COMPOSITIONS AND METHODS FOR TREATMENT OF PLATINUM-BASED CHEMOTHERAPEUTIC RESISTANT TUMORS<br/>[FR] COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DE TUMEURS RÉSISTANT AUX AGENTS CHIMIOTHÉRAPEUTIQUES À BASE DE PLATINE
  申请人：UNIV GEORGE WASHINGTON

  公开号：WO2021178663A1

  公开（公告）日：2021-09-10

  Embodiments of the instant disclosure relate to novel methods and compositions for treating tumors resistant to platinum-based chemotherapy. In certain embodiments, methods of treating tumors herein can include administering an effective amount of at least one ursolic acid derivative. In certain embodiments, methods of treating tumors herein can include administering an effective amount of at least one ursolic acid derivative in combination with at least one platinum-based chemotherapeutic separately or in a combination therapy. In some embodiments, methods of treating tumors disclosed herein can include screening and/or selecting a subject suitable for treatment on the basis of SENP1 tumor expression. In other embodiments, methods of treating tumors can include administering a composition disclosed herein to a subject, the composition having a combination of at least one ursolic acid derivative and at least one platinum-based chemotherapeutic.

  本公开的实施例涉及用于治疗对铂类化疗药物具有抗药性的肿瘤的新方法和组合物。在某些实施例中，治疗此处肿瘤的方法可以包括给予至少一种熊果酸衍生物的有效量。在某些实施例中，治疗此处肿瘤的方法可以包括给予至少一种熊果酸衍生物的有效量，单独或与至少一种铂类化疗药物联合治疗。在一些实施例中，治疗此处肿瘤的方法可以包括根据SENP1肿瘤表达筛选和/或选择适合治疗的受试者。在其他实施例中，治疗肿瘤的方法可以包括将本文披露的组合物给予受试者，该组合物包含至少一种熊果酸衍生物和至少一种铂类化疗药物。
• URSOLIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF
  申请人：Lin Chun-Nan

  公开号：US20110190388A1

  公开（公告）日：2011-08-04

  Several ursolic acid derivatives and pharmaceutical compositions thereof are provided. The ursolic acid derivatives and the pharmaceutical compositions thereof have at least one of an anticancer and an anti-inflammatory effects. A method for increasing a reactive oxygen species in a cell is also provided. The method comprises a step of providing the cell with a pharmaceutical composition including an ursolic acid derivative.

  提供了几种熊果酸衍生物及其药物组合物。这些熊果酸衍生物和药物组合物具有抗癌和抗炎作用中的至少一种。还提供了一种增加细胞中活性氧自由基的方法。该方法包括向细胞提供包含熊果酸衍生物的药物组合物的步骤。
• NOVEL INHIBITORS OF BACTERIAL BIOFILMS AND RELATED METHODS
  申请人：Sequoia Sciences, Inc.

  公开号：US20130274256A1

  公开（公告）日：2013-10-17

  Certain multi-cyclic compounds and compositions thereof are useful for reducing or inhibiting the growth of bacterial biofilms and for controlling bacterial biofilm infections. Such compounds and compositions are also useful in methods for reducing or inhibiting the growth of biofilms and for controlling bacterial biofilm infections involving biofilms.

  某些多环化合物及其组合物可用于减少或抑制细菌生物膜的生长并控制细菌生物膜感染。这些化合物和组合物还可用于减少或抑制生物膜的生长并控制涉及生物膜的细菌生物膜感染的方法。
• Ursolic acid for inhibiting muscle atrophy
  申请人：University of Iowa Research Foundation

  公开号：EP2571354B1

  公开（公告）日：2020-07-08
• Novel inhibitors of bacterial biofilms and related methods
  申请人：Sequoia Sciences, Inc.

  公开号：EP2712863B1

  公开（公告）日：2014-10-22